Photo by Ester FantHOUSTON—(Oct. 02, 2006)—On a recent Thursday, Thomas Walker picked up a Houston Chronicle and read an article that would change his life.
John D. Reveille, M.D., (right) professor and director of the Division of Rheumatology and Clinical Immunogenetics at The University of Texas Medical School at Houston, and senior research assistant Laura Diekman, work with Thomas Walker (left) during a recent appointment at the University Clinical Research Center. Walker is enrolled in a clinical trial that is studying the effectiveness of a medication for ankylosing spondylitis.
John D. Reveille, M.D., professor and director of the Division of Rheumatology and Clinical Immunogenetics at The University of Texas Medical School at Houston, was recruiting patients with ankylosing spondylitis to participate in a clinical trial.
Walker, 66, was intrigued by the news. He had been living with the arthritic condition since the mid-1970s, and he was willing to test a medication that may loosen his stiff joints and alleviate pain in his spine and shoulders.
Walker, 66, was intrigued by the news. He had been living with the arthritic condition since the mid-1970s, and he was willing to test a medication that may loosen his stiff joints and alleviate pain in his spine and shoulders.
He quickly called the telephone number listed in the newspaper article. It led him to the University Clinical Research Center, or UCRC, where he became one of thousands of patients to enroll in trials that help shape the future of medicine.
No comments:
Post a Comment